Thomas Grotkjær

Thomas joined Novo Holdings in 2017 and is Partner in the Planetary Health Investments team where he also oversees the Nordic early-stage activities.

Prior to joining Novo Holdings, Thomas worked in business development at Novozymes where he introduced advanced yeast technology to the biofuel industry and built a portfolio of biochemical projects. Earlier in this career, he was part of the venture capital backed start-up company Fluxome Sciences. He also held positions in biotechnology research and process engineering at Toftejorg (now Alfa Laval) and the Carlsberg Breweries.

Thomas holds a PhD in Metabolic Engineering and a MSc in Chemical Engineering from the Technical University of Denmark as well as graduate diplomas in Business Administration (Marketing Management and Finance) from Copenhagen Business School.